Evaluation of the Use of Antihypertensive Agents in Ischemic Stroke Patients Hospitalized in West Nusa Tenggara Hospital, Indonesia
DOI:
https://doi.org/10.30595/pharmacy.v18i1.9343Keywords:
antihypertension, ischemic stroke, rational evaluation of drug useAbstract
Antihypertensive agents are one of the drugs recommended on ischemic stroke patients as a secondary therapy for prevention of occurrence repeated stroke and reduce the risk of brain edema. If the management of hypertension is incorrect on ischemic stroke patient can worsen the patient's condition and affect mortality. The use of antihypertensive drugs must be evaluated accordingly with rational use of drugs. This study aims to examine the accuracy of the use of antihypertensive drugs in ischemic stroke patients which includes right indication, right patient, right medicine, right dose and right frequency. This research is a cross sectional descriptive study using medical record data of 19 ischemic stroke patients. The inclusion criteria of the study were all ischemic stroke hospitalization patients and receiving antihypertensive drugs therapy. The evaluation of accuracy was done descriptively by comparing research data to the literature which includes JNC VII & VIII, PERDOSSI 2011, PIONAS 2015, FORNAS and Revised RSUDP Formulary 6th. The results showed the accuracy of use antihypertensive agents is 100% that is 100% precise indication; 100% right patient; 100% right dose; and 95% right frequency. The type of inaccuracy encountered is frequency imprecision drug administration, therefore the role of a pharmacist in hospital are needed as part of efforts to improve the accuracy of the use of drugs in ischemic stroke patients.
References
American Heart Association (AHA). 2013. Heart Disease and Stroke Statistics: Circulation.
American Heart Association (AHA). 2018. Guidelines for the Early Management of Patients With Acute Ischemic Stroke.
Departemen Kesehatan Republik Indonesia. 2006. Pharmaceutical Care Untuk Penyakit Hipertensi, Jakarta: Departemen Kesehatan Republik Indonesia
Perhimpunan Dokter Spesialis Saraf Indonesia. 2011. Pedoman Penatalaksanaan Stroke. Himpunan Dokter Spesialis Saraf Indonesia. Jakarta.
Joint National Committee 8. 2014. The Eight Report of the Joint National Committee. Hypertension Guidelines: An In-Depth Guide. Am J Manag Care.
Kementrian Kesehatan. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian Di Rumah Sakit. 2016. Jakarta: Depertemen Kesehatan Republik Indonesia.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan. 2018. Riset Kesehatan Dasar. Jakarta: Kementerian Kesehatan Republik Indonesia
Appelrosp., Stegmayr B., and Tarent A. 2009. Sex Differences in Stroke Epidemiology : A sistematic Review. Stroke, 40, 1082-1090
Gorgui, Jessica., Gorshkov, Maxim., Khan, Nadia., Daskalopoulou, Stella.S. 2014. Hypertension as a Risk Factor for Ischemic Stroke in Women. No. 30:Canadian Journal of Cardiology.
Goldstein L.B. 2006. Primary Prevention Of Ischemic Stroke, vol 37: American Heart Association.Inc
Gofir, A. 2011. Manajemen stroke. Yogyakarta : Pustaka Cendekia Press.
Kirshner, H.S., 2009. Differentiating Ischemic Stroke Subtypes: Risk Factors and Secondary Prevention, Journal The Neurological Sciences, 279(2009), 1-8
Muir, W.Keith. 2013. Stroke. Medicine Volume 41.No.3.
Munaf, Sjamsuir. 2004. Pengantar Farmakologi. In: Kumpulan Kuliah Farmakologi. Edisi 2. Jakarta: Penerbit Buku Kedokteran EGC.
Natoadmodjo, S. 2012. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
Padiastuti, D.R., 2013, Penyakit pemicu stroke, Yogyakarta: Muha Medika
Sassen, J. J. & Erick, J. M. 2008, Hypertension in Dipro, J. T., Robert, L. T., Gary, C. Y., Gary, R, M., barbara, G. W., and Michael, P., Pharmacotherapy Approach, Sevent Edition, America. The Mac Graw Hill.
World Health Organization. 2006. STEP Stroke Surveillance Volume 2.1.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
